SCHEMBL20122364

SCHEMBL20122364

Cc1oc(=O)oc1COC(=O)[C@H](CSC(=O)OCOC(=O)C(C)C)NC(=O)C(C)(C)S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122437 0.97 — —
SCHEMBL20122547 0.91 — —
SCHEMBL20122441 0.91 MME (0.31) —
SCHEMBL20122518 0.90 — —
SCHEMBL20122559 0.87 CYP1A2 (0.33) —
SCHEMBL20122548 0.87 — —
SCHEMBL20122563 0.86 MME (0.30) —
SCHEMBL20122496 0.86 ACE (0.34) —
SCHEMBL20122564 0.85 — —
SCHEMBL20122560 0.84 CYP1A2 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963428-B1 Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-05-08 — — US disclosed
Send feedback